Quantinuum Inc. (NASDAQ:QNT – Get Free Report)’s stock price traded down 8.2% on Monday . The stock traded as low as $64.55 and last traded at $64.64. 666,721 shares changed hands during mid-day trading, a decline of 82% from the average daily volume of 3,752,017 shares. The stock had previously closed at $70.45.
Wall Street Analysts Forecast Growth
Several research firms have commented on QNT. Wall Street Zen cut shares of Quantinuum from a “hold” rating to a “sell” rating in a report on Saturday, July 4th. UBS Group initiated coverage on shares of Quantinuum in a research report on Monday, June 29th. They set a “buy” rating and a $93.00 price objective for the company. Zacks Research upgraded shares of Quantinuum to a “hold” rating in a research note on Tuesday, June 30th. Bank of America began coverage on Quantinuum in a research note on Monday, June 29th. They issued a “buy” rating and a $100.00 price target on the stock. Finally, Sanford C. Bernstein initiated coverage on Quantinuum in a research report on Monday, June 29th. They set an “outperform” rating and a $94.00 price objective for the company. Twelve analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Quantinuum presently has a consensus rating of “Moderate Buy” and a consensus target price of $98.75.
Read Our Latest Stock Report on QNT
Quantinuum Stock Performance
Insider Activity
Quantinuum Company Profile
Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.
The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.
Featured Stories
- Five stocks we like better than Quantinuum
- Why Welltower’s Growth Story Might Outrun Its Rich Valuation
- One Short- and One Long-Term ETF for Quantum Computing Bulls
- The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions
- Why Micron Is Doubling Down While the HBM Shortage Persists
Receive News & Ratings for Quantinuum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantinuum and related companies with MarketBeat.com's FREE daily email newsletter.
